Replies to post #397562 on Amarin Corp Plc (AMRN)

[Number sleven]

Pdude, Well reasoned post.
Sleven,

[mrmainstreet]

Man I couldn't disagree with you more PDude. This mgmt team has been a disaster and lost 95% of the value with a damn golden goose drug. I'll take new blood and a proven track record, as it's about time someone kicked ass.

[couldbebetter]

Pharmacydude, All of us investors want to see shareholder value maximized
and the uptake of Vascepa optimized. My view remains that only a BP owning
AMRN can accomplish this. KM was hired for his expertise on getting approvals
and reimbursements in Europe. Germany was certainly a major disappointment.
If AMRN had been owned by a BP such as Bayer (with deep connections to
Germany) I wonder if the negotiations would have had a different outcome.
AMRN has always lacked the "gravitas" of a BP. Imagine if Pfizer decided
that Vascepa would be a viable treatment for COVID induced CVD. My guess
is that if COVID induced CVD were deemed to be a serious enough problem
they could find a way to get governments to pay for it. My impression is that
KM has no interest in selling the company. I think Denner would actively
solicit the best possible deal for all concerned.

[oneragman]

Pdude, the problem I have is that I believe AMRN management would use any positive stock price to dilute to aquire a pipeline. Isn't the guy they just added to the board today brought on for that purpose? He certainly wasn't added to sell the company.